17 results for “weed-care”
The first academic research on Switzerland’s landmark adult-use pilot, has reported a decline in problematic consumption, particularly among those who used other drugs in addition to cannabis. Europe’s first adult-use […]
Swiss company Cannavigia is supporting the pilot with its track and trace software.
Astrasana and Clever Leaves have partnered to establish an international supply agreement for medical cannabis extracts in Czech Republic and Switzerland. Clever Leaves Holdings Inc, a global medicinal cannabis company, […]
Thousands of Swiss residents have access to legal adult-use cannabis, while patients say they are still struggling to get prescriptions.
A citizens’ initiative to legalise cannabis gained more than 50,000 signatures.
We take a look at the meaning behind 420 and reflect on the moves towards reform across Europe.
The plans are expected to see the roll out of the limited legalisation of cannabis in Germany by the end of the year.
Reports from Germany indicate that the draft law could include decriminalisation and cultivation for personal use.
The UK is poised to become Europe’s second largest medical cannabis market this year.
Zurich will be the second Swiss city to legalise the sale and consumption of limited amounts of cannabis for personal use.
Major developments are expected in both adult-use and medical cannabis legislation.
Thousands of patients in Greece are still relying on the illicit market despite the rescheduling of medical cannabis in 2017.
Following new recommendations, is France taking the first tentative steps towards cannabis reform?
The company has been granted a licence for the production of high-THC active pharmaceutical ingredients (APIs) by Swissmedic.
Could cannabis be your secret weapon for staying alcohol-free in 2023?
Experts predict what the year ahead could hold for cannabis consumers across Europe and beyond.
From groundbreaking studies to patient perspectives, here’s what happened in the world of UK cannabis (and beyond) in 2022
